Shared and divergent phase separation and aggregation properties of brain-expressed ubiquilins
Julia E. GersoniD, Hunter Linton, Jiazheng Xing, Alexandra B. SutteriD, Fayth S. Kakos, Jaimie H. Ryou, Nyjerus Liggans, Lisa M. SharkeyiD, Nathaniel SafreniD, Henry Lauris PaulsoniD, Magdalena I. IvanovaiD
Abstract
The brain-expressed ubiquilins, UBQLNs 1, 2 and 4, are highly homologous proteins that participate in multiple aspects of protein homeostasis and are implicated in neurodegenerative diseases. Studies have established that UBQLN2 forms liquid-like condensates and accumulates in pathogenic aggregates, much like other proteins linked to neurodegenerative diseases. However, the relative condensate and aggregate formation of the three brain-expressed ubiquilins is unknown. We report that the three ubiquilins differ in aggregation propensity, revealed by in-vitro experiments, cellular models, and analysis of human brain tissue. UBQLN4 displays heightened aggregation propensity over the other ubiquilins and, like amyloids, UBQLN4 forms ThioflavinT-positive fibrils in vitro. Measuring fluorescence recovery after photobleaching (FRAP) of puncta in cells, we report that all three ubiquilins undergo liquid-liquid phase transition. UBQLN2 and 4 exhibit slower recovery than UBQLN1, suggesting the condensates formed by the brain-expressed ubiquilins have different compositions and undergo distinct internal rearrangements. We conclude that while all brain-expressed ubiquilins exhibit self-association behavior manifesting as condensates, they follow distinct courses of phase-separation and levels of aggregation. This variability among ubiquilins along the continuum from liquid-like to solid likely informs both the normal ubiquitin-linked functions of ubiquilins and their accumulation and potential contribution to toxicity in various neurodegenerative diseases.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 24
- FWCI
- 1.18
- Field percentile
- top 24%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Short N-terminal disordered regions and the proline-rich domain are major regulators of phase transitions for full-length UBQLN1, UBQLN2 and UBQLN4
T. P. Dao, A. Rajendran, … C. A. Castaneda·bioRxiv·Sep 27, 2023
- Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia
Laura R. Nementzik, Kyrah M. Thumbadoo, … Emma L. Scotter·bioRxiv·Feb 10, 2023
- Ubiquilin-2 liquid droplets catalyze α-synuclein fibril formation
Tomoki Takei, Yukiko Sasazawa, … Nobutaka Hattori·The EMBO JournalPeer-reviewed·Oct 14, 2025
- E3 ligase recruitment by UBQLN2 protects substrates from proteasomal degradation
Ashley Scheutzow, Sachini Thanthirige, … Matthew L. Wohlever·bioRxiv·Jul 4, 2024
- Mechanistic insights into the enhancement or inhibition of phase separation by polyubiquitin chains of different lengths or linkages
T. P. Dao, Y. Yang, … C. A. Castaneda·bioRxiv·Nov 12, 2021
- Phase separation of polyubiquitinated proteins in UBQLN2 condensates controls substrate fate
Isabella M. Valentino, Jeniffer G. Llivicota-Guaman, … Daniel Adam Kraut·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 9, 2024